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Tetralogy of Fallot with absent 
pulmonary valve syndrome: A 34-year 
African single centre experience
TETRALOGY 
OF FALLOT
A common finding in these patients is 22q11.2 deletion, with 
a frequency of approximately 44%.(9) The presence of the 
22q11.2 deletion is important to exclude because of the 
association with immunodeficiency, a worse prognosis and 
reduced survival.(10) 
The survival rates after surgical intervention have improved 
over time. In a recent Australian study, the overall operative 
mortality was 13.5% over a 38-year period. However, they 
showed no operative mortality in 15 consecutive patients 
ABSTRACT
Background: Absent pulmonary valve syndrome (APVS) 
is most commonly associated with Tetralogy of Fallot 
(TOF). TOF with APVS is characterised by features of 
TOF with either rudimentary ridges or complete 
absence of pulmonary valve tissue. This is often asso-
ciated with varying degrees of pulmonary stenosis and 
severe pulmonary regurgitation with massive dilatation 
of the proximal branch pulmonary arteries, causing 
compression of the tracheobronchial tree. Hence, respi-
ratory symptoms are a common presenting feature.
Methods: Cases of TOF with APVS were extracted 
from the paediatric cardiology database at Chris Hani 
Baragwanath Academic Hospital (CHBAH) for January 
1981 -  April 2016.
Results: A total of 15 patients with TOF and APVS were 
seen at CHBAH over the 34-year study period. TOF 
with APVS comprised 3% of all TOF patients. Ten (67%) 
patients presented before 1 year of age. The majority of 
patients (67%) had respiratory symptoms as their cause 
of presentation, of which 6 (40%) were infants. Fourteen 
(93%) patients were described to have the characteristic 
to-and-fro murmur at presentation. Five patients (33%) 
were suspected of having 22q11.2 deletion syndrome, 
but only 4 were tested and 2 were found to be positive. 
A third of patients underwent surgical intervention and 
4 of the 15 patients (27%) were known to be alive at 10 
years of age.
Conclusions: TOF with APVS compromised 3% of all 
TOF patients, correlating with the literature. It is asso-
ciated with the 22q11.2 deletion syndrome and was 
suspected in 33% of patients. TOF with APVS should be 
strongly considered in a child less than 1 year presenting 
with respiratory symptoms and a characteristic to-and-
fro murmur.  SAHeart 2018;15:128-132
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INTRODUCTION
Absent pulmonary valve syndrome (APVS) is a rare congenital 
cardiac abnormality most commonly associated with Tetralogy 
of Fallot (TOF). It occurs in 3% - 6% of all infants and children 
presenting with TOF.(1,2) It was first described in 1864.(3) APVS 
with TOF is characterised by features of TOF with either rudi-
mentary ridges or complete absence of the pulmonary valve 
tissue. This results in varying degrees of pulmonary stenosis 
and severe pulmonary regurgitation with massive dilatation of 
the proximal branch pulmonary arteries and compression of 
the tracheobronchial tree. Hence, respiratory symptoms are 
a common presenting feature in this condition.(4,5) 
In the current era, patients with this condition can be confi-
dently diagnosed in utero with foetal echocardiography.(6) 
However, foetal echocardiography is not readily available in 
public hospitals in resource constrained countries, making pre-
natal diagnosis uncommon. Approximately 40% - 50% of these 
patients present as infants with respiratory symptoms ranging 
from stridor to severe respiratory compromise, requiring 
mechanical ventilation.(5,7) Patients who present with respiratory 
symptoms early in life continue to pose a major clinical challenge 
associated with relatively high mortality rates, typically in the 
20% - 30% range.(5,7) Preoperative ventilation predicts longer 
postoperative ventilation and increased mortality.(8)
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since 2001. They attributed improved results over the last 12 
years of the study to a combination of increased surgical 
experience, the application of extensive branch pulmonary 
artery reduction techniques and a trend towards increased 
utilisation of valved conduits. The overall survival in this study 
was 81.4% ± 5.6% at 10 years.(8) 
There is currently no literature emanating from Africa that has 
been published on TOF with APVS. The aim of the study was 
to review the characteristics and outcomes of patients pre-
senting with this condition at a tertiary African referral hospital.
METHODS
Data was sourced from the Chris Hani Baragwanath Academic 
Hospital (CHBAH), which is situated in the low-middle income 
South African township of Soweto, near Johannesburg. It serves 
a population of approximately 1.25 million people, including 
128 000 children under 5-years of age.(11,12) Using a paediatric 
cardiology electronic database, cases of TOF and APVS were 
identified over a 34-year period from January 1981 - April 
2016. Additional information, not obtainable from the database, 
was sought from patient files and extracted onto a standardised 
data collection form. Data collected included: age, gender, 
details of initial presentation, maternal history, anthropometry, 
clinical examination, results of genetic tests, chest x-ray reports, 
electrocardiography reports, echocardiography reports, angio-
graphy reports, surgical complications and outcomes which 
included morbidity and mortality.
Permission to undertake this research was obtained from the 
Human Research Ethics Committee (Medical) of the University 
of the Witwatersrand and the Medical Advisory Committee of 
CHBAH.
RESULTS
A total of 15 patients with TOF and APVS were seen over 
the 34-year study period (Table 1). APVS compromised 3% 
(15/514) of all TOF patients. 
Of the 15 patients, over two-thirds (67%) were male. Ten 
(67%) patients presented before 1 year of age. The majority of 
patients (67%) had respiratory symptoms as their cause of 
presentation, of whom 6 (40%) were infants.
Fourteen (93%) patients were described to have the charac-
teristic systolic and diastolic (to-and-fro) cardiac murmur on 
clinical examination at presentation. 
Seven patients (47%) were recorded to be dysmorphic. The 
FISH analysis for 22q11.2 deletion was introduced at our 
institution in 1994, therefore documentation of testing was 
recorded from this period onwards. Five out of 11 (46%) 
patients which presented after 1994 were suspected to have 
had 22q11.1 deletion. Of these 5 patients, 2 patients were 
positive for 22q11.2 deletion, 1 patient was negative for 
22q11.2 deletion, 1 patient’s blood was rejected by the 
laboratory and 1 patient was not tested. An additional patient 
showed phenotypical features of Noonan’s syndrome for 
which there is presently no genetic test available in South 
Africa (Table 1). 
A number of patients with TOF and APVS had other asso-
ciated cardiac features. Six patients (40%) were documented 
to have a right aortic arch. Both patients that were positive for 
22q11.2 deletion had a left aortic arch. Of the other 3 patients 
that were suspected to have 22q11.2 deletion, only 2 patients 
had a right aortic arch. Patient 6 (Table 1) had a small secundum 
atrial septal defect (ASD) and a left superior vena cava (SVC) 
diagnosed on echocardiography. Patient 12 had a single right 
coronary artery and a left SVC draining into the coronary sinus. 
Patient 13 was documented to have a 4mm secundum ASD. 
Patient 14 had a quadricuspid aortic valve, but no aortic stenosis 
or regurgitation was noted. 
Only 5 (33%) patients underwent surgical intervention (Table 1). 
The majority were done between 1981 and 1998, and in 
children older than a year of age.
Patient 1 had a transannular patch and ventricular septal defect 
(VSD) closure at 9 years of age, followed by placement of 
a pulmonary homograft and closure of a small residual VSD 
2 years later. Patient 3 had a VSD closure at 11 years of age. 
According to the surgical notes reconstruction of the pulmonary 
outflow tract was not done because the pulmonary valve 
dysfunction was deemed to be mild at the time. Patient 8 had 
a pulmonary homograft and VSD closure at 8 years of age. 
Patient 12 had reconstruction of the main pulmonary artery 
and VSD closure at 2 years of age. Patient 14 had a pulmonary 
homograft and VSD closure at 6 months of age at a private 
hospital. Patient 9 planned to have surgery abroad and was 
lost to follow up. There were no records of surgical interven-
tion in the other patients.
Recently a patient with TOF and APVS, who presented at 
26 months of age with an incidental murmur, underwent 
bronchoscopy to assess the severity of bronchial compression 
pre-operatively. The bronchoscopy showed 90% compres-
sion of the right main bronchus and 30% of the left main 
bronchus. The patient has been lost to follow up without 
surgery being done. 
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Review of follow-up data showed that 7 (47%) patients were 
known to be alive at 1 year of age while 4 (27 %) were known 
to be alive at 10 years of age. One patient died during the 
neonatal period. The follow up of patients improved over the 
last 3 years of the study period. Three out of the 4 patients 
that have presented since 2014, continue to be followed up at 
the cardiac clinic.
Figures 1 - 4 show 2 echocardiographic and 2 angiographic 
images for Patient 13 which demonstrate typical features of 
TOF with APVS.
TABLE I: Characteristics of patients with TOF and APVS.
No.
Year of 
presenta-
tion
Sex
Age of 
presentation
Symptoms on 
presentation
Syndromes Surgical intervention Alive Notes
1 1981 Male 2 months Shortness of breath Not dysmorphic
Transannular patch and VSD 
closure in 1990. Pulmonary 
homograft and closure of 
small residual VSD in 1992
Unsure Last seen 2012
2 1982 Male 5 weeks Incidental murmur
Phenotypical 
features of 
Noonan’s 
syndrome
Nil Unsure Last seen 1997
3 1983 Female 14 months Respiratory distress Not dysmorphic
VSD closure only in 1993. 
Pulmonary homograft 
not done
Unsure
Last seen 1997. 
Was awaiting 
pulmonary 
homograft 
4 1994 Male 12 days Respiratory distress Not dysmorphic Not done Unsure Last seen 1995 
5 1994 Female 1 month Incidental murmur
Clinically 22q11.2 
deletion syndrome. 
Blood specimen 
rejected
Not done Unsure
Last seen 1994. 
Plan was for cardiac 
catheterisation
6 1995 Male Day 1 of life
Respiratory distress, 
distended abdomen
Suspected 22q11.2 
deletion syndrome. 
Not tested
Nil No
Died in ICU at 
1 month of age, 
ventilated since 
birth
7 1997 Male 4 months
Cough and 
shortness of breath
Not dysmorphic Not done Unsure
Last seen 
cardiac clinic 
8 1998 Female 7 years
Cough and 
incidental cardiac 
murmur
Not dysmorphic
Pulmonary homograft and 
VSD closure in 1998
Unsure Last seen 1999
9 1998 Male 10 years
Incidental cardiac 
murmur
Not dysmorphic
Not done. For surgical 
intervention abroad as 
requested by family
Unsure Last seen 1998
10 2005 Male Day 1 of life
Mild respiratory 
distress with cardiac 
murmur
Not dysmorphic Not done Unsure
Last seen 2005. 
Was for cardiac 
catheterisation in 
6 months’ time
11 2008 Female 2 months
Gastroenteritis. 
Incidental cardiac 
murmur
Positive for 22q11.2 
deletion syndrome
Not done Unsure Last seen 2008
12 2014 Male 1 year 1 month Respiratory distress
Positive for 22q11.2 
deletion syndrome
Reconstruction of pulmonary 
artery and VSD closure in 
2015. Transannular patch 
or pulmonary homograft 
not done
Yes Last seen 2016
13 2015 Female 2 year 2 months Cardiac murmur
Negative for 
22q11.2 deletion 
syndrome
Awaiting surgery Yes
Last seen 2016 –
awaiting surgery
14 2015 Male 6 months
Respiratory distress 
with incidental 
cardiac murmur
Not dysmorphic
Pulmonary homograft and 
VSD closure in 2016
Unsure
Patient transferred 
to private hospital
15 2016 Male 8 months
Shortness of breath 
with incidental 
cardiac murmur
Dysmorphic Not done yet Yes Last seen 2016
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DISCUSSION
To our knowledge, this is the first African study on TOF with 
APVS. No literature pertaining to TOF and APVS in Africa 
could be found using an online literature search. Our data is 
in agreement with the published literature which shows that 
APVS is a rare congenital cardiac lesion, compromising 3% 
of all TOF patients.(1,2) Ten (67%) patients presented before 
1 year of age in our study. Typically, patients with TOF and 
APVS are divided into 2 categories: those who present early 
with respiratory symptoms (infant-type APVS) and those who 
present later (childhood-type).(5,13) The majority of the study 
patients (67%) had respiratory symptoms as their cause of 
presentation, of which 6 (40%) were infants. A to-and-fro 
murmur (ejection systolic and early diastolic murmur) at the 
left sternal border is a characteristic clinical sign in TOF and 
APVS.(7,13) The majority of our patients (93%) had a to-and-
fro murmur on clinical examination which was diagnostic at 
presentation. Given the limited availability of prenatal ultra-
sound in a resource poor setting like ours, TOF and APVS 
should be suspected in a child less than 1 year presenting with 
respiratory symptoms and a characteristic to-and-fro murmur.
As 22q11.2 deletion is a common finding in patients with TOF 
and APVS, routine screening for this deletion should be 
FIGURE 1: (Patient 13) Echocardiographic image in the 
parasternal short axis view: The pulmonary valve (thick 
arrow) appears thickened. The main pulmonary artery is 
massive compared to the ascending aorta (thin arrow). 
FIGURE 3: (Patient 13) Right ventricle angiogram in the 
ROA 40, cranial 20 view. The main pulmonary artery (thick 
arrow) and branch pulmonary arteries are massive. Doming of 
the pulmonary valve (thin arrow) can be appreciated.
FIGURE 4: (Patient 13) Ascending aorta angiogram in 
the AP view showing a right aortic arch with a mirror 
image branching pattern. The fi rst branch arising from the 
ascending aorta (arrow) is the innominate artery. 
FIGURE 2: (Patient 13) Echocardiographic image showing 
severe pulmonary stenosis (velocity >4cm/s, star) and 
pulmonary regurgitation (PHT 54ms, arrow) using 
continuous wave Doppler across the pulmonary valve.
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encouraged. The 22q11.2 deletion syndrome was suspected 
in 5 out of 11 of patients (46%). According to the literature, the 
frequency of this deletion in TOF with APVS is approximately 
44%.(9) The laboratory test for 22q11.2 deletion was introduced 
in 1994, therefore the patients presenting before this testing 
era were not tested. Routine screening for confirmation of 
22q11.2 deletion in patients with TOF and APVS should be 
routine particularly because of its association with other com-
plications such as immunodeficiency and mental retardation 
which has an impact on management and outcome.(9,10) 
TOF with APVS may occasionally be associated with defects 
such as atrial septal defects and absent left pulmonary artery.(13) 
Two patients had an ASD secundum and 2 patients had a left 
SVC. A right aortic arch has been previously documented in 
approximately 70% of patients who are positive for 22q11.2 
deletion.(8) In our study, 40% of patients were found to have a 
right aortic arch, however, both patients that were confirmed 
positive for 22q11.2 deletion had a left aortic arch. Of the other 
3 patients that were suspected to have 22q11.2 deletion, 2 had 
a right aortic arch.
Only 1 of our patients underwent bronchoscopy as part of a 
pre-operative assessment of the airways. Bronchoscopy has 
been shown to be a beneficial pre-operative investigation to 
assess the degree of airway compression and to guide surgical 
management. A recent study on airway compression manage-
ment in late-presenting APVS showed 7 out of 19 (37%) 
patients had pre-operative evidence on bronchoscopy of airway 
compression that needed surgical intervention. Four patients 
underwent a pulmonary artery reduction plasty and 3 patients 
underwent the Lecompte manoeuvre.(14) 
Adequate surgical data was available in only 5 patients. Of 
the 10 remaining un-operated patients, only 1 was confirmed 
to have died before 5 weeks of age. The other 9 patients were 
lost to follow up and may have died, or have had surgery at 
another institution. One patient was documented to have 
travelled abroad for surgery. Patients referred to our institution 
include patients from neighbouring provinces and countries 
who are difficult to trace.
Follow-up data of the study patients is poor, with only 4 (27%) 
of the 15 patients known to be alive at 10 years of age. One 
patient died in the neonatal period. Seven (47%) patients were 
alive at 1 year of age. The potential for good outcomes was 
documented in a study by Yong et al. in Australia over a 38-year 
period, which showed that the overall survival at 10 years was 
81.4% ± 5.6%.(8) 
In conclusion, TOF with APVS is a rare condition compromising 
3% of all TOF patients presenting to an African tertiary care 
centre, which correlates with the mainstream literature. The 
22q11.2 deletion syndrome was suspected in 33% of patients 
but confirmed in a small number (13%), largely due to several 
of our patients presenting prior to the availability of routine 
testing. APVS should be suspected in a child less than 1 year 
presenting with respiratory symptoms and a characteristic to-
and-fro murmur. A good outcome can be expected if diag-
nosed early and the appropriate surgical management provided.
The limitations of the study were that the data was analysed 
retrospectively at a single institution which has historically 
experienced numerous resource constraints, and where follow 
up of patients has been poor. As such, any inferences drawn 
from these data were limited.
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